# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
TEANECK, N.J.--(BUSINESS WIRE)-- Phibro Animal Health Corporation (NASDAQ:PAHC), a global leader in animal health and nutritio...
B of A Securities analyst Derik De Bruin maintains Phibro Animal Health (NASDAQ:PAHC) with a Underperform and raises the pri...
U.S. stock futures were swinging on Thursday following Wednesday's advances. Futures of major benchmark indices were largel...
Phibro shares soared nearly 18% after strong Q4 results beat estimates, driven by growth from the Zoetis MFA acquisition and so...
Phibro Animal Health (NASDAQ:PAHC) is looking for FY2026 Adj EPS of $2.52-$2.70 vs $2.03 analyst estimate. sees sales of $1.430...